The effect of citric acid-modified enzyme-resistant dextrin on growth and metabolism of selected strains of probiotic and other intestinal bacteria

Journal of Functional Foods

Volumn 2, Issue 2, 2010, Pages 126-133

  Barczynska, Renata ^a   Jochym, Kamila ^b   Slizewska, Katarzyna ^a   Kapusniak, Janusz ^b   Libudzisz, Zdzislawa ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); SOLANUM TUBEROSUM;

EID: 77954861526     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2010.03.002     Document Type: Article

References (61)

1. Asp N.G., Van Amelsvoort J.M.M., Hautvast J.G.A.J. Nutritional implications of resistant starch. Nutrition Research Review 1996, 9:1-31.
2. Ballongue J., Schumann C., Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scandinavian Journal of Gastroenterology 1997, 222(Suppl.):41-44.
3. Bouhnik Y., Flourié B., D'Agay-Abensour L., Pochart P., Gramet G., Duran M., et al. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. Journal of Nutrition 1997, 127:444-448.
4. Bouhnik Y., Vahedi K., Achour L., Attar A., Salfati J., Pochart P., et al. Short chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. Journal of Nutrition 1999, 129:113-116.
5. Brendel, R., Boursier, B., & Leroux, P. (2002). US. Patent 2002/0192344 A1.
6. Cambell J.H., Fahey G.C., Wolf B.W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH, and microflora in rats. Journal of Nutrition 1997, 127:130-136.
7. Crittenden R.G. Production, properties and applications of food-grade oligosaccharides. Trends in Food Science and Technology 1996, 7:353-361.
8. Crittenden R.G., Playne M.J. Purification of food-grade oligosaccharides using immobilised cells of Zymomonas mobilis. Applied Microbiology and Biotechnology 2002, 58:297-302.
9. Cummings J.H., Beatty E.R., Kingman S.M., Bingham S.A., Englyst H.N. Digestion and physical properties of resistant starch in the human large bowel. British Journal of Nutrition 1996, 75:733-747.
10. Diplock A.T., Aggett P.J., Ashwell M., Bornet F., Fern E.B., Roberfroid M.B. Scientific concepts of functional foods in Europe: Consensus document. British Journal of Nutrition 1999, 81(Suppl. 1):S1-S27.
11. Englyst H.N., Kingman S.M., Cummings J.H. Classification and measurement of nutritionally important starch fractions. European Journal of Clinical Nutrition 1992, 46(Suppl.):S33-S50.
12. Flickinger E.A., Wolf B.W., Garleb K.A., Chow JoMay, Leyer G.J., Johns P.W., et al. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs. Journal of Nutrition 2000, 130:1267-1273.
13. Fouache, C., Duflot, P., & Looten, P. (2003). US. Patent 6630,586.
14. Fuller R. Probiotics in human medicine. Gut 1991, 32:439-442.
15. Fuller R. Probiotics. The scientific basis 1992, Chapman & Hall, London.
16. Gibson G. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. Journal of Nutrition 1999, 129(Suppl. 7):1438S-1441S.
17. Gibson G.R., Probert H.M., Van Loo J., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 2004, 17:259-275.
18. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. Journal of Nutrition 1995, 125:1401-1412.
19. Hopkins M.J., Cummings J.H., Macfarlane G.T. Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. Journal of Applied Microbiology 1998, 85:381-386.
20. Kaneko T., Kohmoto T., Kikuchi H., Shiota M., Iino H., Mitsuoka T. Effects of isomaltooligosaccharides with different degrees of polymerization on human fecal bifidobacteria. Bioscience Biotechnology and Biochemistry 1994, 58:2288-2290.
21. Kaneko T., Yokoyama A., Suzuki M. Digestibility characteristics of isomaltooligosaccharides in comparison with several saccharides using the rat jejunum loop method. Bioscience Biotechnology and Biochemistry 1995, 59:1190-1194.
22. Kapusniak J., Barczynska R., Slizewska K., Libudzisz Z. Utilization of enzyme-resistant chemically modified dextrins from potato starch by Lactobacillus bacteria. Zeszyty Problemowe Poste{ogonek}pów Nauk Rolniczych 2008, 530:445-457. (in Polish, with English abstract).
23. Kapusniak J., Jochym K., Barczynska R., Slizewska K., Libudzisz Z. Preparation and characteristics of novel enzyme-resistant chemically modified dextrins from potato starch. Zeszyty Problemowe Poste{ogonek}pów Nauk Rolniczych 2008, 530:427-444. (in Polish, with English abstract).
24. Kohmoto T., Fukui F., Takaku H., Mitsuoka T. Dose-response test of isomaltooligosaccharides for increasing fecal bifidobacteria. Agricultural and Biological Chemistry 1991, 55:2157-2159.
25. Lee Y.-K., Salminen S. The coming age of probiotics. Trends in Food Science and Technology 1995, 6:241-245.
26. Lefranc-Millot, C., Wils, D., Neut, C., Saniez-Degrave, M.H. (2006). Effects of a soluble fiber, with excellent tolerance, NUTRIOSE® 06, on the gut ecosystem: A review. In Proceedings of The dietary fibre conference. Helsinki, Finland.
27. Leszczynski W. Resistant starch-classification, structure, production. Polish Journal of Food Nutrition Sciences 2004, 13/54(SI 1):37-50.
28. Libudzisz Z., Kowal K. Mikrobiologia techniczna 2007, Wyd. Naukowe PWN, tom I. Warszawa, (in polish).
29. Matsuda, I., and Satouchi, M. (1997). Agent for promoting the proliferation of Bifidobacterium. US. Patent 5,698,437.
30. Nugent A.P. Health properties of resistant starch. British Nutrition Foundation Nutrition Bulletin 2005, 30:27-54.
31. Ohkuma, K., Hanno, Y., Inada, K., Matsuda, I., & Katta, Y. (1997). US. Patent 5,620,873.
32. Ohkuma K., Wakabayashi S. Fibersol-2: A soluble, non-digestible, starch-derived dietary fibre. Advanced dietary fibre technology 2001, 509-523. Oxford, Blackwell Science Ltd. B.V. McCleary, L. Prosky (Eds.).
33. Okazaki M., Fujikawa S., Matsumoto N. Effects of xylooligosaccharide on growth of bifidobacteria. Journal of the Japanese Society for Nutrition and Food Science 1990, 43:395-401.
34. Panel on the Definition of Dietary Fiber, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food, Nutrition Board Dietary reference Intakes: Proposed definition of dietary fiber 2001, The National Academies Press, Washington.
35. Pasman W.J., Wils D., Saniez M-H., Kardinaal A.F. Long term gastro-intestinal tolerance of NUTRIOSE® FB in healthy men. European Journal of Clinical Nutrition 2006, 60(8):24-1034.
36. Roberfroid M.B. Prebiotics and synbiotics: Concepts and nutritional properties. British Journal of Nutrition 1998, 80(4):S197-S202.
37. Roberfroid M.B. Concepts in functional foods: the case of inulin and oligofructose. Journal of Nutrition 1999, 129:1398S-1401S.
38. Roberfroid M.B. Functional food concept and its application to prebiotics. Digestive and Liver Disease 2002, 34(Suppl. 2):S105-S110.
39. Roberfroid M.B. Introducing inulin-type fructans. Journal of Nutrition 2005, 93:S13-S25.
40. Roberfroid M.B. Inulin-type fructans: Functional food ingredients. Journal of Nutrition 2007, 137:2493S-2502S.
41. Roberfroid M.B., Van Loo J.A.E., Gibson G.R. The bifidogenic nature of chicory inulin and its hydrolysis products. Journal of Nutrition 1998, 128:11-19.
42. Roturier, J.M., and Looten, P.H. (2006). Nutriose® - Analytical aspects. In Proceedings of The dietary fibre conference. Helsinki, Finland.
43. Roturier, J.M., Looten, P.H., Osterman, E. (2003). Dietary fiber measurement in food containing NUTRIOSE® FB by enzymatic-gravimetric-HPLC method. In Proceedings of dietary fiber. Helsinki, Finland.
44. Sako T., Matsumoto K., Tanaka R. Recent progress on research and applications of non-digestible galacto-oligosaccharides. International Dairy Journal 1999, 9:69-80.
45. Sanders M.E. Probiotics: Considerations for human health. Nutrition Review 2003, 61(3):91-99.
46. Saniez, M.-H. (2004). US. Patent 6,737,414 B2.
47. Serpelloni, M. (2002). US. Patent 2002/01,92,343 A1.
48. Serpelloni, M. (2003). US. Patent 2003/0077368 A1.
49. Serpelloni, M. (2006). US. Patent 2006/0112956 A1.
50. Shahidi F. Nutraceuticals, functional foods: Whole versus processed foods. Trends in Food Science and Technology 2009, 20:376-387.
51. Sungsoo Cho S., Samuel P. Fiber ingredients: Food applications and health benefits 2009, CRC Press, Boca Raton.
52. Swennen K., Courtin Ch.M., Delcour J.A. Non-digestible oligosaccharides with prebiotic properties. Critical Reviews in Food Science and Nutrition 2006, 46:459-471.
53. Topping D.L., Clifton P.M. Short-chain fatty acids, human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiological Review 2001, 81(3):1031-1064.
54. Tuohy K.M., Ziemer C.J., Klinder A., Knöbel Y., Pool-Zobel B.L., Gibson G.R. A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microbial Ecology in Health and Disease 2002, 14:165-173.
55. Tuohy K.M., Probert H.M., Smejkal C.W., Gibson G.R. Using probiotics and prebiotics to improve gut health. Drug Discovery Today 2003, 8(15):692-700.
56. Unno T., Nagata K., Horiguchi T. Effects of green tea supplemented with indigestible dextrin on postprandial levels of blood glucose and insulin in human subjects. Journal of Nutritional Food 2002, 5(2):31-39.
57. van den Heuvel E.G., Wils S.D., Pasman W.J., Bakker M., Saniez M.H., Kardinaal A.F. Short-term digestive tolerance of different doses of NUTRIOSE® FB, a food dextrin, in adult men. European Journal of Clinical Nutrition 2004, 58(7):1046-1055.
58. Van Loo J., Cummings J., Delzenne N., Englyst H., Franck A., Hopkins M., et al. Functional food properties of non-digestible oligosaccharides: A consensus report from the ENDO project (DGXII AIRII-CT94-1095). British Journal of Nutrition 1999, 81:121-132.
59. Wynne A.G., McCartney A.L., Brostoff J., Hudspith B.N., Gibson G.R. An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities. Anaerobe 2004, 10:165-169.
60. Yamamoto T. Effect of indigestible dextrin on visceral fat accumulation. Journal of Japanese Society For the Study of Obesity 2007, 13:34-41.
61. Ziemer Ch.J., Gibson G.R. An overview of probiotics, prebiotics and synbiotics in the functional food concept. Perspectives and future strategies. International Dairy Journal 1998, 8:473-479.